These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 31206982)

  • 1. Comparative effectiveness of common therapies for Wilson disease: A systematic review and meta-analysis of controlled studies.
    Appenzeller-Herzog C; Mathes T; Heeres MLS; Weiss KH; Houwen RHJ; Ewald H
    Liver Int; 2019 Nov; 39(11):2136-2152. PubMed ID: 31206982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of D-penicillamine, trientine, and zinc in pediatric Wilson disease patients.
    Lee EJ; Woo MH; Moon JS; Ko JS
    Orphanet J Rare Dis; 2024 Jul; 19(1):261. PubMed ID: 38982450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Drug Managements of Wilson's Disease: From West to East.
    Li WJ; Chen C; You ZF; Yang RM; Wang XP
    Curr Neuropharmacol; 2016; 14(4):322-5. PubMed ID: 26639459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of oral chelators in treatment of patients with Wilson disease.
    Weiss KH; Thurik F; Gotthardt DN; Schäfer M; Teufel U; Wiegand F; Merle U; Ferenci-Foerster D; Maieron A; Stauber R; Zoller H; Schmidt HH; Reuner U; Hefter H; Trocello JM; Houwen RH; Ferenci P; Stremmel W;
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1028-35.e1-2. PubMed ID: 23542331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant immune-related events in Wilson disease: implications for monitoring chelator therapy.
    Seessle J; Gotthardt DN; Schäfer M; Gohdes A; Pfeiffenberger J; Ferenci P; Stremmel W; Weiss KH
    J Inherit Metab Dis; 2016 Jan; 39(1):125-30. PubMed ID: 26067812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Switching Pharmacological Treatment in Wilson Disease: Case Report and Recommendations.
    Leung M; Wu Lanzafame J; Medici V
    J Investig Med High Impact Case Rep; 2020; 8():2324709619896876. PubMed ID: 31920114
    [No Abstract]   [Full Text] [Related]  

  • 7. Zinc Therapy for Wilson Disease in Children in French Pediatric Centers.
    Santiago R; Gottrand F; Debray D; Bridoux L; Lachaux A; Morali A; Lapeyre D; Lamireau T
    J Pediatr Gastroenterol Nutr; 2015 Dec; 61(6):613-8. PubMed ID: 26230903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Wilson's disease: what are the relative roles of penicillamine, trientine, and zinc supplementation?
    Schilsky ML
    Curr Gastroenterol Rep; 2001 Feb; 3(1):54-9. PubMed ID: 11177695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wilson disease - currently used anticopper therapy.
    Członkowska A; Litwin T
    Handb Clin Neurol; 2017; 142():181-191. PubMed ID: 28433101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical recommendations and new therapies for Wilson's disease.
    Brewer GJ
    Drugs; 1995 Aug; 50(2):240-9. PubMed ID: 8521757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and treatment of Wilson's disease.
    Subramanian I; Vanek ZF; Bronstein JM
    Curr Neurol Neurosci Rep; 2002 Jul; 2(4):317-23. PubMed ID: 12044251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Wilson disease: an update].
    Seo JK
    Korean J Hepatol; 2006 Sep; 12(3):333-63. PubMed ID: 16998287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Wilsons disease].
    Mareček Z; Brůha R
    Vnitr Lek; 2013 Jul; 59(7):578-83. PubMed ID: 23909262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wilson disease.
    El-Youssef M
    Mayo Clin Proc; 2003 Sep; 78(9):1126-36. PubMed ID: 12962167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease.
    Brewer GJ; Askari F; Lorincz MT; Carlson M; Schilsky M; Kluin KJ; Hedera P; Moretti P; Fink JK; Tankanow R; Dick RB; Sitterly J
    Arch Neurol; 2006 Apr; 63(4):521-7. PubMed ID: 16606763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to different therapeutic approaches in Wilson disease. A long-term follow up study.
    Rodríguez B; Burguera J; Berenguer M
    Ann Hepatol; 2012; 11(6):907-14. PubMed ID: 23109455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of Wilson's disease, a rare genetic disorder of copper metabolism.
    Purchase R
    Sci Prog; 2013; 96(Pt 1):19-32. PubMed ID: 23738435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of Wilson disease].
    Smolarek C; Stremmel W
    Z Gastroenterol; 1999 Apr; 37(4):293-300. PubMed ID: 10378366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trientine induced colitis during therapy for Wilson disease: a case report and review of the literature.
    Boga S; Jain D; Schilsky ML
    BMC Pharmacol Toxicol; 2015 Nov; 16():30. PubMed ID: 26589720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial.
    Schilsky ML; Czlonkowska A; Zuin M; Cassiman D; Twardowschy C; Poujois A; Gondim FAA; Denk G; Cury RG; Ott P; Moore J; Ala A; D'Inca R; Couchonnal-Bedoya E; D'Hollander K; Dubois N; Kamlin COF; Weiss KH;
    Lancet Gastroenterol Hepatol; 2022 Dec; 7(12):1092-1102. PubMed ID: 36183738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.